SCOPUS 정보 검색 플랫폼

Cerebrovascular Diseases

Volumn 11, Issue 1, 2001, Pages 20-29

Glycine antagonist (GV150526) in acute stroke: A multicentre, double-blind placebo-controlled phase II trial

(7) Lees, K R a Lavelle, J F b Cunha, L c Diener, H C d Sanders, E A C M e Tack, P f Wester, P g

a WESTERN INFIRMARY (United Kingdom)

b GLAXOSMITHKLINE (United Kingdom)

c CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA (Portugal)

d UNIVERSITY OF DUISBURG ESSEN (Germany)

e Ignatius Hospital (Netherlands)

f Sint Andriesziekenhuis (Belgium)

g UMEÅ UNIVERSITY HOSPITAL (Sweden)

Author keywords

Acute stroke; Clinical trial; Glycine antagonist; GV150526; Neuroprotection

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; GAVESTINEL; HEMOGLOBIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEVER; HUMAN; HYPERBILIRUBINEMIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STROKE;

AGED; BILIRUBIN; CEREBROVASCULAR ACCIDENT; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; GLYCINE; GLYCINE AGENTS; HUMANS; INDOLES; NEUROPROTECTIVE AGENTS; QUALITY OF LIFE; SAFETY; TREATMENT OUTCOME;

EID: 0035137210 PISSN: 10159770 EISSN: None Source Type: Journal
DOI: 10.1159/000047607 Document Type: Article

Times cited : (34)

References (15)

1
- 0002098178
- Pharmacological characterisation of the novel glycine antagonist GV150526: In vitro studies
- (1995) Eur J Neurol , vol.2 , pp. 57-58
- Ratti, E.¹ Corsi, M.² Carignani, C.³ Cugola, A.⁴ Nugnaini, M.⁵ Gaviraghi, G.⁶ Trist, D.⁷ Reggiani, A.⁸

2
- 0026701712
- Excitatory amino acids antagonists and their potential for the treatment of ischaemic brain damage in man
- (1992) Br J Clin Pharmacol , vol.34 , pp. 106-114
- McCulloch, J.¹

3
- 0023091647
- Glycine potentiates the NMDA response in cultured mouse brain neurones
- (1987) Nature , vol.325 , pp. 529-531
- Johnson, J.W.¹ Ascher, P.²

4
- 0030739272
- The glycine antagonist GV150526 protects somatosensory evoked potential and reduces the infarct area in the MCAO model of focal ischaemia in the rat
- (1997) Exp Neurol , vol.145 , pp. 425-433
- Bardi, F.¹ Pietra, C.² Ziviani, L.³ Reggiani, A.⁴

5
- 0031886652
- Duration of neuroprotective treatment for ischaemic stroke
- (1998) Stroke , vol.29 , pp. 535-542
- Dyker, A.G.¹ Lees, K.R.²

6
- 0000499937
- The safety, tolerability and pharmacokinetics of GV150526 in patients with acute stroke
- (1997) Stroke , vol.28 , pp. 233
- Dyker, A.G.¹ Lees, K.R.² Preston, C.³ Caveggion, E.⁴

7
- 0006168493
- Pharmacokinetics of GV150526 following multiple intravenous doses in acute stroke patients
- (1997) Cerebrovasc Dis , vol.7 , Issue.SUPPL. 4 , pp. 29
- Hoke, J.F.¹ Dyker, A.G.² McAllister, A.M.³ Lees, K.R.⁴

8
- 0006174942
- Resource utilisation assessment of acute stroke treatment (GLYB2002)
- (1999) Cerebrovasc Dis , vol.9 , Issue.SUPPL. 1 , pp. 113
- Wallace, M.¹ Cargill, K.² Lees, K.R.³

9
- 0023770007
- A prospective study of acute cerebrovascular disease in the community: The Oxfordshire Community Stroke Project 1981-1986: Methodology, demography and incident cases of first ever stroke
- (1998) J Neurol Neurosurg Psychiatry , vol.51 , pp. 1373-1380
- Bamford, J.¹ Sandercock, P.² Dennis, M.³ Warlow, C.⁴ Jones, L.⁵ McPherson, K.⁶ Vessey, M.⁷ Fowler, G.⁸ Molyneux, A.⁹ Hughes, T.¹⁰ Burn, J.¹¹ Wade, D.¹²

10
- 0004130139
- Bath, Blackwell Science
- (1996) Stroke: A Practical Guide for Management
- Warlow, C.¹ Dennis, M.S.² Van Gijn, J.³ Hankey, G.J.⁴ Sandercock, P.A.G.⁵ Bamford, J.⁶ Wardlaw, J.⁷

11
- 0031886782
- Complication of acute ischaemic stroke
- (1998) Cerebrovasc Dis , vol.8 , pp. 124-132
- Kapelle, L.J.¹ Van der Warp, H.B.²

12
- 0026754346
- Primary intracerebral haemorrhage in the Jyvaskyla region, central Finland, 1985-1989: Incidence, case fatality rate and functional outcome
- (1995) J Neurol Neurosurg Psychiatry , vol.55 , pp. 546-552
- Fogelholm, R.¹ Nuutila, M.² Vuorela, A.L.³

13
- 0030069170
- Lubeluzole in acute ischaemic stroke: A double-blind placebo-controlled phase II trial
- (1996) Stroke , vol.27 , pp. 76-81
- Diener, H.C.¹ Hacke, W.² Hennerici, M.³ Radberg, J.⁴ Hantson, L.⁵ De Keyser, J.⁶

14
- 0032925354
- Safety and tolerability of GV150526 (a glycine site antagonist at the NMDA receptor) in patients with acute stroke
- (1999) Stroke , vol.30 , pp. 986-992
- Dyker, A.¹ Lees, K.R.²

15
- 0006218375
- GAIN Investigators: University of Virginia Neuroclinical Trials Centre and Glaxo Wellcome: Phase II studies of the glycine antagonist, GV150526, in acute stroke (GAIN) preliminary results
- Orlando, Fla.
- (1998) 23rd Int Conf Stroke Cereb Circ

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.